ClinConnect ClinConnect Logo
Search / Trial NCT04247334

Inhibitory Control: Effects of Modulation

Launched by BUTLER HOSPITAL · Jan 28, 2020

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

ClinConnect Summary

**Clinical Trial Summary: Inhibitory Control: Effects of Modulation**

This clinical trial is looking at how certain brain networks involved in controlling our impulses work in healthy young adults. Impulse control is important for managing various conditions like substance abuse, obsessive-compulsive disorder, and attention-deficit hyperactivity disorder. The researchers aim to use a technique called neuromodulation to see if they can improve how these brain networks function and, in turn, enhance performance on tasks that require good impulse control. By understanding these brain mechanisms better, the hope is to improve treatments for people who struggle with impulse control issues.

If you are a healthy young adult aged 18 to 35 and are fluent in English, you might be eligible to participate in this study. Participants will be grouped based on their impulse control abilities, as measured by a specific test. However, if you have certain medical conditions, a history of seizures, or are currently taking psychiatric medications, you may not be able to join. Those who participate can expect to undergo various assessments, including an MRI, and to engage in tasks designed to test their impulse control. This study could contribute to meaningful advancements in how we treat impulse control disorders in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Low (\<1sd below the mean on the BRIEF-Inhibit) or high (\>1sd above the mean on BRIEF-Inhibit scale)
  • 2. English fluency to ensure comprehension of study measures and instructions.
  • Exclusion Criteria:
  • 1. Presence of medical conditions contraindicated for tDCS, including history of any known intracranial pathology, epilepsy or seizures, traumatic brain injury, brain tumor, stroke, implanted medical devices, current pregnancy or women of childbearing age not using effective contraception, or any other serious medical conditions or health problems that would interfere with participation (e.g., skin condition)
  • 2. Inability to undergo MRI
  • 3. Current substance abuse disorder
  • 4. Currently prescribed psychiatric medications.
  • 5. Active mania or psychosis

About Butler Hospital

Butler Hospital is a leading psychiatric and behavioral health facility dedicated to advancing mental health care through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital focuses on developing and evaluating new therapeutic interventions, aiming to improve treatment outcomes for patients with various mental health conditions. With a commitment to evidence-based practice, Butler Hospital collaborates with a multidisciplinary team of experts to ensure rigorous methodology and ethical standards in all research endeavors, ultimately enhancing the quality of care for individuals in need.

Locations

Providence, Rhode Island, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials